Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Kopran Ltd

NSE: KOPRAN · BSE: 524280 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹274.55
Market cap
₹1,327 Cr
Revenue (annual)
₹681.4 Cr
Net profit (annual)
₹25.73 Cr
P/E (TTM)
53.1×Sector 47.4×
Promoter holding
44.42%+0.00% QoQ
FII holding
0.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

22:18 IST BSE
Acquisition

Kopran Acquisition

Kopran Limited shareholders and creditors approved the Scheme of Amalgamation with Kopran Laboratories Limited. The resolution passed with requisite majority during the NCLT-convened meetings.

15:31 IST BSE
Acquisition

Kopran Acquisition

Kopran Limited announced meetings for shareholders and creditors on June 03, 2026, to approve the merger by absorption of Kopran Laboratories Limited. The amalgamation is pursuant to an NCLT Mumbai Bench order dated April 09, 2026. This consolidation aims to merge the transferor entity into the transferee company.